Skip Navigation LinksHome > September 2013 - Volume 32 - Issue 9 > Optimization of Continuous Infusion of Piperacillin–Tazobact...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e318298dfb8
Antimicrobial Reviews

Optimization of Continuous Infusion of Piperacillin–Tazobactam in Children With Fever and Neutropenia

Delvallée, Mélanie MD*†; Mazingue, Françoise MD†‡; Abouchahla, Wadi MD†‡; Delebarre, Mathilde MD†‡; Wallet, Frédéric MD*†; Courcol, René MD, PhD*†; Kipnis, Eric MD, PhD†§¶; Dessein, Rodrigue MD, PhD*†¶

Collapse Box


The study through Monte Carlo simulation of β-lactam pharmacokinetic/pharmacodynamic target attainment and determination of subsequent serum concentrations of piperacillin–tazobactam administered through continuous infusion to children treated for fever and neutropenia shows that 400 mg/kg/day has the highest probability of target attainment against Pseudomonas aeurginosa in our oncology ward compared with the standard regimen of 300 mg/kg/day.

© 2013 by Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.